ARG54562

anti-Factor XII Light chain antibody [C6B7]

anti-Factor XII Light chain antibody [C6B7] for ELISA and Human

Cell Biology and Cellular Response antibody; Immune System antibody

Overview

Product Description Mouse Monoclonal antibody [C6B7] recognizes Factor XII Light chain
Tested Reactivity Hu
Tested Application ELISA
Specificity This antibody reacts with the light chain of human Factor XII and at 100 nM inhibits 50% of Factor XII activity
Host Mouse
Clonality Monoclonal
Clone C6B7
Isotype IgG1
Target Name Factor XII Light chain
Antigen Species Human
Immunogen Purified human Factor XII.
Conjugation Un-conjugated
Alternate Names Hageman factor; Coagulation factor XII; HAF; EC 3.4.21.38; HAEX; Beta-factor XIIa part 2; HAE3

Application Instructions

Application Note This antibody may be used in ELISA to detect/quantitate Factor XII and in coagulation assays. Other applications are under investigation.
* The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Protein G-purified
Buffer PBS (pH 7.4)
Storage Instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C or below. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Bioinformation

Database Links

GeneID: 2161 Human F12

Swiss-port # P00748 Human Coagulation factor XII

Gene Symbol F12
Gene Full Name coagulation factor XII (Hageman factor)
Background This gene encodes coagulation factor XII which circulates in blood as a zymogen. This single chain zymogen is converted to a two-chain serine protease with an heavy chain (alpha-factor XIIa) and a light chain. The heavy chain contains two fibronectin-type domains, two epidermal growth factor (EGF)-like domains, a kringle domain and a proline-rich domain, whereas the light chain contains only a catalytic domain. On activation, further cleavages takes place in the heavy chain, resulting in the production of beta-factor XIIa light chain and the alpha-factor XIIa light chain becomes beta-factor XIIa heavy chain. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then to beta-factor XIIa. The active factor XIIa participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. It activates coagulation factors VII and XI. Defects in this gene do not cause any clinical symptoms and the sole effect is that whole-blood clotting time is prolonged. [provided by RefSeq, Jul 2008]
Function Factor XII is a serum glycoprotein that participates in the initiation of blood coagulation, fibrinolysis, and the generation of bradykinin and angiotensin. Prekallikrein is cleaved by factor XII to form kallikrein, which then cleaves factor XII first to alpha-factor XIIa and then trypsin cleaves it to beta-factor XIIa. Alpha-factor XIIa activates factor XI to factor XIa. [UniProt]
Research Area Cell Biology and Cellular Response antibody; Immune System antibody
Calculated MW 68 kDa
PTM Factor XII is activated by kallikrein in alpha-factor XIIa, which is further converted by trypsin into beta-factor XIIa. Alpha-factor XIIa is composed of an NH2-terminal heavy chain, called coagulation factor XIIa heavy chain, and a COOH-terminal light chain, called coagulation factor XIIa light chain, connected by a disulfide bond. Beta-factor XIIa is composed of 2 chains linked by a disulfide bond, an N-terminal nonapeptide, called beta-factor XIIa part 1, and coagulation factor XIIa light chain, also known in this context as beta-factor XIIa part 2.
O- and N-glycosylated. The O-linked polysaccharides were not identified, but are probably the mucin type linked to GalNAc.